DJS ANTIBODIES LTDActive

Company number 09140967Private limited companyIncorporated 2014
⚠ Accounts overdue. The next accounts were due on 30 Sep 2026 and had not been filed when the register was last updated.

Key figures

£2,510,483+409.4%
Net assets 2021/22
+438.1%
Average annual growth 2019/20–2021/22
-1 m01 m2 m3 m2019/202020/212021/22

Like most small UK companies, DJS ANTIBODIES LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2021/22
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02.5 m5 m7.5 m2019/202020/212021/22
Filed accounts2019/20–2021/22
2019/202020/212021/22
Cash at bank and in hand238,8765,129,3391,251,574
Total assets492,0115,511,8282,556,672
Total liabilities425,6476,444,127209,084
Net assets / total equity86,705-811,3772,510,483
Average number of employees5712

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: DJS ANTIBODIES LTD

Company

DJS ANTIBODIES LTD is a private limited company registered with Companies House under company number 09140967. It was incorporated on 21 Jul 2014. Its status is active. The registered office is in Oxford (OX3). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).

Accounts

The latest accounts in the database are for 2021/22 (period ending 31 Jul 2022); the company files small company accounts. Net assets were £2,510,483, up 409.4% on the previous year. Cash at bank and in hand was £1,251,574. Total assets were £2,556,672 and total liabilities £209,084. The company had an average of 12 employees. Figures are available for 3 financial years (2019/20–2021/22).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Sep 2026. The next confirmation statement is due by 4 Aug 2027.